Your browser is no longer supported. Please, upgrade your browser.
OGEN [AMEX]
Oragenics, Inc.
Index- P/E- EPS (ttm)-0.43 Insider Own0.20% Shs Outstand102.97M Perf Week-7.84%
Market Cap81.42M Forward P/E- EPS next Y-0.20 Insider Trans-94.97% Shs Float101.43M Perf Month0.34%
Income-26.50M PEG- EPS next Q-0.04 Inst Own9.00% Short Float2.56% Perf Quarter-26.52%
Sales- P/S- EPS this Y-27.00% Inst Trans5.81% Short Ratio0.84 Perf Half Y62.40%
Book/sh0.32 P/B2.13 EPS next Y0.00% ROA-135.60% Target Price- Perf Year27.97%
Cash/sh0.31 P/C2.23 EPS next 5Y- ROE-224.50% 52W Range0.38 - 2.09 Perf YTD51.92%
Dividend- P/FCF- EPS past 5Y32.10% ROI- 52W High-66.23% Beta0.27
Dividend %- Quick Ratio42.30 Sales past 5Y- Gross Margin- 52W Low87.19% ATR0.05
Employees7 Current Ratio42.30 Sales Q/Q- Oper. Margin- RSI (14)46.95 Volatility4.97% 6.24%
OptionableNo Debt/Eq0.00 EPS Q/Q54.90% Profit Margin- Rel Volume0.51 Prev Close0.68
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.08M Price0.71
Recom2.00 SMA20-2.96% SMA50-1.44% SMA200-3.54% Volume616,996 Change3.46%
May-18-21 07:30AM  
May-03-21 07:30AM  
Apr-09-21 10:50AM  
Mar-09-21 12:09PM  
07:00AM  
Mar-08-21 07:30AM  
Feb-12-21 08:00AM  
Feb-02-21 08:00AM  
Jan-14-21 07:00AM  
Jan-07-21 07:00AM  
Dec-29-20 04:00PM  
Dec-24-20 08:30AM  
Dec-02-20 09:37AM  
Nov-24-20 11:37AM  
Nov-20-20 08:30AM  
Nov-19-20 05:14PM  
Oct-06-20 07:30AM  
Sep-28-20 07:30AM  
Sep-11-20 07:30AM  
Sep-03-20 09:47AM  
Aug-20-20 08:30AM  
Jul-22-20 07:30AM  
Jul-10-20 07:30AM  
Jun-04-20 08:00AM  
Jun-03-20 09:00AM  
May-19-20 08:01AM  
May-08-20 05:45AM  
May-04-20 06:15AM  
06:00AM  
Apr-15-20 06:30AM  
Mar-09-20 10:50AM  
Dec-10-19 11:16AM  
Dec-03-19 08:30AM  
Dec-02-19 09:45AM  
08:30AM  
Nov-15-19 08:00AM  
Nov-11-19 10:22AM  
Oct-22-19 08:00AM  
Oct-02-19 08:15AM  
Sep-30-19 08:00AM  
Sep-25-19 08:00AM  
Sep-23-19 08:00AM  
Sep-10-19 10:41AM  
Sep-06-19 05:29PM  
Aug-20-19 08:00AM  
Jul-10-19 09:46AM  
Jun-25-19 08:30AM  
Jun-17-19 08:00AM  
Jun-07-19 01:30PM  
May-20-19 07:45AM  
May-13-19 09:07AM  
Apr-24-19 12:00PM  
Apr-04-19 10:00AM  
Mar-28-19 08:00AM  
Mar-27-19 08:00AM  
Mar-25-19 04:00PM  
Mar-21-19 06:00AM  
Mar-20-19 05:16PM  
04:40PM  
Mar-18-19 02:00PM  
Mar-15-19 04:17PM  
12:00AM  
Feb-22-19 07:32AM  
Jan-31-19 01:15PM  
Jan-28-19 08:37AM  
Jan-25-19 01:45PM  
Dec-03-18 07:05AM  
06:50AM  
Nov-27-18 08:30AM  
Nov-26-18 03:30PM  
08:45AM  
Nov-19-18 12:15PM  
Nov-15-18 04:15PM  
Nov-14-18 07:27PM  
Nov-13-18 07:27PM  
Oct-30-18 11:15AM  
Oct-18-18 08:00AM  
Oct-17-18 07:30AM  
Oct-12-18 08:00AM  
Oct-10-18 10:30AM  
Oct-05-18 12:05PM  
Oct-04-18 10:30AM  
08:19AM  
Oct-02-18 10:30AM  
Sep-25-18 07:45AM  
Sep-24-18 08:00AM  
07:20AM  
Sep-17-18 03:49PM  
09:13AM  
Aug-17-18 01:30PM  
Aug-15-18 07:30AM  
Jul-27-18 07:55AM  
Jul-20-18 09:30AM  
Jul-17-18 04:15PM  
Jul-13-18 08:16AM  
Jun-27-18 07:20AM  
Jun-20-18 09:30AM  
Jun-13-18 08:30AM  
Jun-11-18 10:30AM  
Jun-05-18 12:26PM  
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Its lead product candidate under development is OG716, an antibiotic for the treatment of Clostridium difficile. The company also engages in the development and commercialization of Terra CoV-2, a vaccine product candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. Its product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. The company has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and production of lantibiotics, a peptide antibiotic that are naturally produced in gram-positive bacteria. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hernandez Joseph10% OwnerJan 14Sale0.98870,854856,4850Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 13Sale0.80257,510206,008870,854Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 12Sale0.73629,707460,1901,128,364Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 11Sale0.77441,929340,7271,758,071Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 07Sale0.84323,997272,1572,200,000Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 06Sale0.601,000,000600,0002,523,997Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 05Sale0.58500,000290,2003,523,997Jan 26 05:12 PM
Hernandez Joseph10% OwnerJan 04Sale0.52176,00391,5224,023,997Jan 26 05:12 PM
KOSKI ROBERT CDirectorDec 22Sale0.43310,000132,432776,483Dec 23 06:15 PM
Hernandez Joseph10% OwnerDec 02Sale0.415,000,0002,051,5004,200,000Dec 07 06:18 AM
Telling FredDirectorNov 24Buy0.37100,00037,000439,538Nov 25 04:05 PM